Oncolytic Virus Injection
Showing 1 - 25 of >10,000
Cervical Cancer, Endometrial Cancer, Advanced Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type ?
Recruiting
- Cervical Cancer
- +2 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Mar 31, 2023
Osteosarcoma, Sarcoma, Sarcoma,Soft Tissue Trial in Xi'an (Recombinant oncolytic herpes simplex virus type ? (R130))
Recruiting
- Osteosarcoma
- +3 more
- Recombinant oncolytic herpes simplex virus type Ⅰ (R130)
-
Xi'an, Shaanxi, ChinaXi'an Honghui Hospital
May 8, 2023
Ovarian Cancer, Peritoneal Carcinomatosis, Fallopian Tube Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus
Recruiting
- Ovarian Cancer
- +2 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Shanghai, ChinaShanghai Tenth People's Hospital
Mar 26, 2023
Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +9 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Linyi, Shandong, ChinaLinyi Central Hospital
Jul 25, 2023
Sarcoma, Carcinoma, Breast Cancer Trial in Shanghai (Recombinant oncolytic herpes simplex virus type 1 (R130))
Recruiting
- Sarcoma
- +8 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, Jiangsu, ChinaXuzhou Second People's Hospital
May 8, 2023
Head Neck Cancer, Esophageal Cancer, Otorhinolaryngologic Tumors Trial in Shanghai (Recombinant oncolytic herpes simplex virus
Recruiting
- Head and Neck Cancer
- +6 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Shanghai, ChinaEye & ENT Hospital of Fudan University
Apr 13, 2023
Lung Cancer, Bronchial Cancer, Non Small Cell Lung Cancer Trial in Anqing (Recombinant oncolytic herpes simplex virus type 1
Recruiting
- Lung Cancer
- +11 more
- Recombinant oncolytic herpes simplex virus type 1 (R130)
-
Anqing, Anhui, ChinaThe PLA Navy Anqing Hospital
May 23, 2023
Advanced Solid Tumor Trial in Xuzhou (Oncolytic Virus Injection(Revottack)+PD-1)
Not yet recruiting
- Advanced Solid Tumor
- Oncolytic Virus Injection（Revottack）+PD-1
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
Dec 1, 2022
T-cell Lymphoma, Virus, Intravenous Injection Trial (Oncolytic Virus Injection(RT-01))
Not yet recruiting
- T-cell Lymphoma
- +2 more
- Oncolytic Virus Injection(RT-01)
- (no location specified)
May 18, 2022
Advanced Solid Tumor Trial in Xuzhou (Oncolytic Virus Injection(RT-01))
Recruiting
- Advanced Solid Tumor
- Oncolytic Virus Injection(RT-01)
-
Xuzhou, Jiangsu, ChinaThe Affiliated Hospital of Xuzhou Medical University
May 4, 2022
Advanced Solid Tumors Trial in Hangzhou, Shanghai (Recombinant human IL-21 oncolytic vaccinia virus injection)
Not yet recruiting
- Advanced Solid Tumors
- Recombinant human IL-21 oncolytic vaccinia virus injection
-
Hangzhou, Zhejiang, China
- +1 more
Jun 21, 2023
Solid Tumor, Advanced Cancer Trial in Wuxi (Oncolytic Virus Injection(RT-01))
Recruiting
- Solid Tumor
- Advanced Cancer
- Oncolytic Virus Injection(RT-01)
-
Wuxi, Jiangsu, ChinaWuxi People's Hospital
Jan 19, 2022
Advanced Solid Tumor Trial in Wuxi (Oncolytic Virus Injection (RT-01))
Recruiting
- Advanced Solid Tumor
- Oncolytic Virus Injection (RT-01）
-
Wuxi, Jiangsu, ChinaWuxi People's Hospital
Jan 19, 2022
CNS Tumors Trial in Beijing (OH2 injection)
Recruiting
- Central Nervous System Tumors
- OH2 injection
-
Beijing, Beijing, ChinaBeijing Tiantan Hospital, Capital Medical University
Feb 2, 2023
Advanced Solid Tumor, Relapsed/Refractory Lymphoma Trial in Beijing (OVV-01 Injection+IBR900 Cell Injection)
Recruiting
- Advanced Solid Tumor
- Relapsed/Refractory Lymphoma
- OVV-01 Injection+IBR900 Cell Injection
-
Beijing, Beijing, ChinaBeijing Boren Hospital
Mar 4, 2022
Solid Tumor Trial (OH2 Injection)
Not yet recruiting
- Solid Tumor
- OH2 Injection
- (no location specified)
Jul 12, 2023
Solid Tumor Trial (BS006 Injection)
Not yet recruiting
- Solid Tumor
- BS006 Injection
- (no location specified)
Jul 3, 2023
Advanced Bladder Carcinoma Trial in Wuhan (OH2 injection)
Recruiting
- Advanced Bladder Carcinoma
- OH2 injection
-
Wuhan, Hubei, ChinaTongji Hospital, Tongji Medical College of Huazhong University o
Aug 5, 2022
Head Neck Cancer, Melanoma, Breast Cancer Trial in Shanghai (Recombinant L-IFN adenovirus injection)
Recruiting
- Head and Neck Cancer
- +6 more
- Recombinant L-IFN adenovirus injection
-
Shanghai, Shanghai, ChinaShanghai Fengxian District Central Hospital
Jan 16, 2022
Uterine Cervical Tumors Trial in Wuhan (BS-006)
Not yet recruiting
- Uterine Cervical Neoplasms
- BS-006
-
Wuhan, Hubei, ChinaZhongnan Hospital of Wuhan University
Jun 6, 2022
Pancreatic Cancer Trial in Chongqing (OH2 injection)
Recruiting
- Pancreatic Cancer
- OH2 injection
-
Chongqing, Chongqing, ChinaChongqing University Cancer Hospital
Jan 27, 2022
Non-muscle-invasive Bladder Cancer Trial in Beijing (OH2 injection)
Recruiting
- Non-muscle-invasive Bladder Cancer
- OH2 injection
-
Beijing, Beijing, ChinaNational Cancer Center/Cancer Hospital, Chinese Academy of Medic
Jul 12, 2022
Solid Tumor, Advanced Cancer, Metastatic Cancer Trial in Tampa, Durham (MEM-288 Intratumoral Injection)
Recruiting
- Solid Tumor
- +9 more
- MEM-288 Intratumoral Injection
-
Tampa, Florida
- +1 more
Jun 27, 2022
Tumors Trial in Cangzhou (oncolytic virus (OVV-01) injection)
Recruiting
- Neoplasms
- oncolytic virus (OVV-01) injection
-
Cangzhou, HE BEI, ChinaNorth China Petroleum Bureau General Hospital
Jul 1, 2021
Melanoma Stage IV Trial (Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF), Recombinant
Not yet recruiting
- Melanoma Stage IV
- Recombinant Oncolytic HSV-2 Therapeutic Injecta (Vero Cell) for Human Use (rHSV2hGM-CSF)
- +2 more
- (no location specified)
Sep 27, 2021